Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer
Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have…
Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have…
CAR T-cell therapy, a certain kind of cancer treatment in which the immune system’s T…
Women who ovulate for longer over their lifetimes have a higher risk of developing ovarian…
A specific colonization of microbes in the reproductive tract is commonly found in women with…
Loyalty card data on over-the-counter medicine purchases could help spot ovarian cancer cases earlier according…
Researchers have developed an optimized genetic test for ovarian cancer, which helps accurately target an…
Antibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer…
Two new discoveries led by Cedars-Sinai Cancer investigators in the USA help improve the understanding…
A global study into mucinous ovarian cancer could help oncologists recommend the best treatment for…
Metal-containing complexes have taken up centre stage in the search for new cancer drugs that are…